658 A phase 2 study to assess the safety, efficacy of FLX475 combined with pembrolizumab in patients with advanced or metastatic gastric cancerPaul Rhee, Michael Chisamore, Jaeyong Cho et al.|Regular and Young Investigator Award Abstracts|2022Cited by 2
A phase 2 study to assess the safety and efficacy of FLX475 (tivumecirnon) combined with pembrolizumab in patients with advanced or metastatic gastric cancer.Do‐Youn Oh, Young Su Noh, Min-Hee Ryu et al.|Journal of Clinical Oncology|2025Cited by 0